681 Single pipeline re-analysis revises microbiome associations with anti-tumor response to checkpoint inhibitors

Abstract

BackgroundSeveral studies suggest the gut microbiome may be a novel, modifiable biomarker for clinical efficacy of immune checkpoint inhibitors (ICIs). Microbiome profiling of pre-treatment samples demonstrated that high alpha-diversity and...